1.09
+0.05(+4.81%)
Currency In USD
| Previous Close | 1.04 |
| Open | 1.04 |
| Day High | 1.1 |
| Day Low | 1.03 |
| 52-Week High | 3.09 |
| 52-Week Low | 0.26 |
| Volume | 444,620 |
| Average Volume | 931,296 |
| Market Cap | 200.44M |
| PE | -15.57 |
| EPS | -0.07 |
| Moving Average 50 Days | 1.09 |
| Moving Average 200 Days | 1.08 |
| Change | 0.05 |
If you invested $1000 in Tevogen Bio Holdings Inc. (TVGN) since IPO date, it would be worth $109.66 as of May 09, 2025 at a share price of $1.09. Whereas If you bought $1000 worth of Tevogen Bio Holdings Inc. (TVGN) shares 2 years ago, it would be worth $97.32 as of May 09, 2025 at a share price of $1.09.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest
GlobeNewswire Inc.
May 02, 2025 7:45 PM GMT
WARREN, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that, following the Company’s recent press release highlighting the Direct Registration System (DRS) as a secure method
CD8 Technology Signs Letter of Intent for Tevogen Bio’s In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment
GlobeNewswire Inc.
Apr 30, 2025 7:49 PM GMT
WARREN, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that CD8 Technology Services LLC (“CD8”) has signed a letter of intent for a facility designed to support Tevogen Bio
Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts
GlobeNewswire Inc.
Apr 29, 2025 5:48 PM GMT
WARREN, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today informed shareholders about several differences between holding shares in Direct Registration System (“DRS”) accounts and hold